Open AccessA Four-Year, Open-Label, Multi-Center, Randomized, Two-Arm Study of Genotropin® in Patients with Idiopathic Short Stature: Comparison of an Individualized, Target-Driven Treatment Regimen to Standard Dosing of Genotropin® - Analysis of Two-Year Data
Author(s) -
Debra Counts,
Lawrence A. Silverman,
Mitchell E. Geffner,
Natasa Rajicic,
Judith Hey-Hadavi,
Paul Thornton,
Michael Wajnrajch
Publication year - 2013
Publication title -
hormone research in paediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000354126
Subject(s) - idiopathic short stature , dosing , medicine , bone age , percentile , regimen , clinical endpoint , growth hormone treatment , short stature , pediatrics , open label , randomized controlled trial , growth hormone , hormone , statistics , mathematics
Several models have been developed to predict growth response to growth hormone (GH) based on auxological and biochemical parameters for children with non-GH-deficient, idiopathic short stature (ISS).